Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Nets SBIR Grant from NCI

NEW YORK (GenomeWeb News) – GeneGo said today that it plans to use a Phase I Small Business Innovation Research grant from the National Cancer Institute to develop cancer data analysis software in a collaboration with the Dana-Farber Cancer Institute.
GeneGo said it is developing a system called MetaMiner that will be tailored for biologists, clinicians, and chemists involved in cancer research. The software will combine pathway and network analysis tools, serve as a data repository, and include certain statistical tools.
“We need to understand in a database structure the causal relationships between the involved pathways and the dynamics of pathway activation during tumorigenesis,” GeneGo CEO Yuri Nikolsky said in a statement.
Kornelia Polyak, an associate professor at Dana-Farber involved in the research, said that the effort will focus on development of pathway-based tools to integrate different types of data including somatic mutations, high copy number genes, epigenetics, gene expression, proteomics, and metabolomics.
Genego has received previous SBIR funding from the NCI for another cancer-centered collaboration with Mayo Clinic involving the company’s MetaCore software.
According to an NIH grants database, the one-year SBIR announced today is worth $200,000.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.